Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

ME Legrier, I Bièche, J Gaston, A Beurdeley… - British journal of …, 2016 - nature.com
Background: Oestrogen receptor-negative (ER−) breast cancer is intrinsically sensitive to
chemotherapy. However, tumour response is often incomplete, and relapse occurs with high …

Three vs 6 cycles of chemotherapy for high-risk retinoblastoma: a randomized clinical trial

H Ye, K Xue, P Zhang, R Chen, X Zhai, L Ling, W Xiao… - JAMA, 2024 - jamanetwork.com
Importance Adjuvant therapy is an important and effective treatment for retinoblastoma.
However, there is a lack of head-to-head clinical trials comparing 3 vs 6 cycles of CEV …

Preferentially expressed antigen in melanoma (PRAME) and the PRAME family of leucine-rich repeat proteins

N Hermes, S Kewitz, MS Staege - Current cancer drug targets, 2016 - ingentaconnect.com
Preferentially expressed antigen in melanoma (PRAME) is the best characterized member of
the PRAME family of leucine-rich repeat (LRR) proteins. Mammalian genomes contain …

The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells

X Zhu, L Xue, Y Yao, K Wang, C Tan… - Acta Biochimica et …, 2018 - academic.oup.com
Carboplatin is the most commonly used drug in the first-line treatment of human
retinoblastoma (RB), but its clinical application is greatly limited due to acquired drug …

[HTML][HTML] Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma

M Khan, LL Walters, Q Li, DG Thomas, JML Miller… - Laboratory …, 2015 - Elsevier
Retinoblastoma (RB) is the most common primary intraocular cancer in children, and the
third most common cancer overall in infants. No molecular-targeted therapy for this lethal …

miR-34a regulates the chemosensitivity of retinoblastoma cells via modulation of MAGE-A/p53 signaling

G Yang, Y Fu, X Lu, M Wang… - … Journal of Oncology, 2018 - spandidos-publications.com
The present study aimed to explore the combined role of microRNA (miR)-34a, melanoma
antigen-A (MAGE-A) and p53 in altering the chemosensitivity of retinoblastoma (RB) cells …

Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma

K Shi, X Zhu, J Wu, Y Chen, J Zhang, X Sun - Bioengineered, 2021 - Taylor & Francis
Retinoblastoma is the most common intraocular malignancy during childhood. Currently,
there is no effective treatment for metastatic retinoblastoma. We investigated potential …

TRIM59 promotes retinoblastoma progression by activating the P38–MAPK signaling pathway

C Wu, XQ Shang, ZP You, QF Jin… - … & Visual Science, 2020 - iovs.arvojournals.org
Purpose: Retinoblastoma is a malignant tumor of the developing retina that mostly occurs in
children. Our study aimed to investigate the effect of tripartite motif-containing protein 59 …

UBE2T/STAT3 signaling promotes the proliferation and tumorigenesis in retinoblastoma

N Xu, Y Cui, H Shi, G Guo, F Sun… - … & Visual Science, 2022 - iovs.arvojournals.org
Purpose: The purpose of this paper was to investigate the expression and function of
Ubiquitin-conjugating enzyme 2T (UBE2T), a human E2 ubiquitin-conjugating enzyme, in …

[HTML][HTML] Candidate SNP Markers Significantly Altering the Affinity of the TATA-Binding Protein for the Promoters of Human Genes Associated with Primary Open-Angle …

K Zolotareva, PA Dotsenko, N Podkolodnyy… - International Journal of …, 2024 - mdpi.com
Primary open-angle glaucoma (POAG) is the most common form of glaucoma. This condition
leads to optic nerve degeneration and eventually to blindness. Tobacco smoking, alcohol …